Distance-Based Exercise to Preserve Function and Prevent Disability
Start Date
2/11/2026
Completion Date
8/31/2027
Summary
This clinical trial studies whether an exercise program can be successfully delivered to patients receiving treatment for cancer through virtual sessions and allow patients to exercise in their own home. Treatments for cancer can cause side effects such as fatigue and loss of strength. These side effects can make it difficult to work, take care of family, and do other things the patient wants to do. Preliminary research shows that exercise can help prevent some of these side effects, but it can be more difficult to start an exercise program when a patient is receiving cancer treatment. The exercise program in this study is delivered through telehealth (TH) video calls. The TH sessions are delivered by trained staff that supervise resistance exercises. The trained staff also provide guidance to the patient on completing unsupervised aerobic sessions on their own. This may be a successful way to deliver an exercise program and make it easier for cancer patients to exercise in their own home during treatment.
Detailed Description
PRIMARY OBJECTIVES: I. To establish the feasibility of implementing a virtual exercise intervention trial in a diverse cohort of cancer patients undergoing chemotherapy. SECONDARY OBJECTIVE: I. To establish feasibility of enrolling and retaining a diverse patient population. EXPLORATORY OBJECTIVES: I. Evaluate changes in 6 Minute Walk Test (6MWT) distance in the study population between baseline and the post-chemotherapy time point. II. Evaluate changes in grip strength in the study population between baseline and the post-intervention time point. III. Evaluate objective (accelerometer) and self-reported changes (7-Day Physical Activity Recall Interview) in physical activity in the study population between baseline and the post-intervention time point. IV. Explore the relationship between the predicted 6MWT and the baseline 6MWT. V. Explore changes in patient reported outcomes between baseline, end of intervention, and 3-months post intervention in the study population. VI. Explore employment status over time in the study population. VII. Explore differences intervention adherence and attrition by: 1. Duration of chemotherapy regimen (12 weeks or less vs more than 12 weeks) 2. Administration of chemotherapy in adjuvant vs neoadjuvant setting 3. Administration of cytotoxic chemotherapy alone vs in combination with radiation 4. Administration of cytotoxic chemotherapy alone vs in combination with immunotherapy or other targeted agent (monoclonal antibody, small molecule inhibitor, etc) OUTLINE: Patients complete supervised TH exercise sessions consisting of aerobic exercise over 20 minutes and progressive resistance exercise twice a week (BIW) and complete unsupervised aerobic exercise for a total of 50 minutes per week until the end of standard of care (SOC) chemotherapy or up to a total of 6 months, whichever comes first, in the absence of disease progression or unacceptable toxicity. Patients also receive a stationary bike, workbook, gloves, and resistance bands on study and wear an accelerometer throughout the study. After completion of study intervention, patients are followed up at 4 weeks and 3 months.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Exercise intervention
Telemedicine
Aerobic Exercise Intervention
Exercise Intervention
Accelerometry
Questionnaire Administration
Interview
Electronic Health Record Review
Conditions
Locations
Kaiser Permanente Dublin
Dublin, California 94568
United States
Kaiser Permanente-Fremont
Fremont, California 94538
United States
Kaiser Permanente Fresno Orchard Plaza
Fresno, California 93720
United States
Kaiser Permanente-Modesto
Modesto, California 95356
United States
Kaiser Permanente-Oakland
Oakland, California 94611
United States
Kaiser Permanente-South Sacramento
Sacramento, California 95823
United States
Kaiser Permanente-Santa Teresa-San Jose
San Jose, California 95119
United States
Kaiser San Rafael-Gallinas
San Rafael, California 94903
United States
Kaiser Permanente-Vallejo
Vallejo, California 94589
United States
Dana-Farber Cancer Institute
Boston, Massachusetts 02215
United States
Novant Health Cancer Institute - Kernersville
Kernersville, North Carolina 27284
United States
Novant Health Cancer Institute - Mount Airy
Mount Airy, North Carolina 27030
United States
Novant Health Forsyth Medical Center
Winston-Salem, North Carolina 27103
United States
UPMC Hillman Cancer Center at Butler Health System
Butler, Pennsylvania 16001
United States
IRMC Cancer Center
Indiana, Pennsylvania 15701
United States
UPMC Hillman Cancer Center - New Castle
New Castle, Pennsylvania 16105
United States
University of Pittsburgh Cancer Institute (UPCI)
Pittsburgh, Pennsylvania 15232
United States
UPMC Cancer Center at UPMC Northwest
Seneca, Pennsylvania 16346
United States